ID: ALA2088013

Max Phase: Preclinical

Molecular Formula: C13H9BrClNO2

Molecular Weight: 326.58

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  O=C(Nc1ccc(Br)cc1)c1cc(Cl)ccc1O

Standard InChI:  InChI=1S/C13H9BrClNO2/c14-8-1-4-10(5-2-8)16-13(18)11-7-9(15)3-6-12(11)17/h1-7,17H,(H,16,18)

Standard InChI Key:  RLACRPKMRNEAIU-UHFFFAOYSA-N

Associated Targets(Human)

HepG2 196354 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Mycobacterium tuberculosis 203094 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mycobacterium avium 4587 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mycobacterium kansasii 6484 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mycobacterium marinum 465 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Mycolicibacterium smegmatis 8003 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Pasteurella multocida 1166 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Clostridium perfringens 1165 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Staphylococcus aureus 210822 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Bacillus cereus 7522 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 326.58Molecular Weight (Monoisotopic): 324.9505AlogP: 4.06#Rotatable Bonds: 2
Polar Surface Area: 49.33Molecular Species: NEUTRALHBA: 2HBD: 2
#RO5 Violations: 0HBA (Lipinski): 3HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 7.39CX Basic pKa: CX LogP: 4.13CX LogD: 3.83
Aromatic Rings: 2Heavy Atoms: 18QED Weighted: 0.87Np Likeness Score: -1.43

References

1. Kozic J, Novotná E, Volková M, Stolaříková J, Trejtnar F, Vinšová J..  (2012)  Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues.,  56  [PMID:22907036] [10.1016/j.ejmech.2012.07.044]
2. Pauk K, Zadražilová I, Imramovský A, Vinšová J, Pokorná M, Masaříková M, Cížek A, Jampílek J..  (2013)  New derivatives of salicylamides: Preparation and antimicrobial activity against various bacterial species.,  21  (21): [PMID:24045008] [10.1016/j.bmc.2013.08.029]
3. Krátký M, Volková M, Novotná E, Trejtnar F, Stolaříková J, Vinšová J..  (2014)  Synthesis and biological activity of new salicylanilide N,N-disubstituted carbamates and thiocarbamates.,  22  (15): [PMID:24953953] [10.1016/j.bmc.2014.05.064]
4. Paraskevopoulos G, Monteiro S, Vosátka R, Krátký M, Navrátilová L, Trejtnar F, Stolaříková J, Vinšová J..  (2017)  Novel salicylanilides from 4,5-dihalogenated salicylic acids: Synthesis, antimicrobial activity and cytotoxicity.,  25  (4): [PMID:28126437] [10.1016/j.bmc.2017.01.016]

Source